CGPA:来自癌症基因预后图书馆的多背景见解
Biwei Cao1, Xiaoqing Yu1, Gullermo Gonzalez1
1Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL 33612, USA.
bioRxiv : the preprint server for biology
|August 2, 2024
概括
癌症基因预后图谱 (CGPA) 平台克服了癌症基因预后的无变性分析的局限性. 它可以进行全面的定制分析,以提高生物标志物的发现和验证.
科学领域:
- * 瘤学 在线咨询
- * 生物信息学是一门学科.
- * 计算生物学 * 计算生物学
背景情况:
- * 传统的无变性生存分析不足以捕捉癌症转录基因数据中的基因的预后潜力.
- *这种限制导致潜在的显著预后标记被遗漏,称为无变性错失机会预后 (UMOP) 基因.
- *复杂的预后影响,特别是多重共变量和值,需要先进的分析方法.
研究的目的:
- * 引入癌症基因预测图谱 (CGPA) 作为一个用户友好的平台,用于深入,定制的癌症基因预测分析.
- *通过促进对基因对,基因标志关系和复合生物机制的探索,增强基因中心生物标志物研究.
- *以支持多基因小组评估和使用精选的免疫疗法数据发现预后基因模块.
主要方法:
- * 开发一个交互式的,基于网络的平台 (CGPA) 来定制癌症基因表达数据的预后分析.
- * 整合探索基因对和基因标志关联的能力,并分析多基因组.
- *包括一个门户,用于从癌症免疫治疗数据集中识别预后基因模块.
主要成果:
- *CGPA为研究人员提供了一个可访问的界面,无论他们的统计专业知识如何,他们都可以研究基因预测景观.
- *该平台支持对复杂的生物机制的数据驱动探索,如合成致死性和免疫抑制.
- *CGPA促进了机制对机器分析和预后基因模块的发现.
结论:
- *CGPA通过提供全面和可定制的预后分析工具,大大推进了癌症基因生物标志物研究.
- * 该平台使研究人员能够精确调查基因预后值,增强生物标志物发现和验证.
- *CGPA整合了机械见解与数据驱动的策略,以实现理解癌症预后的协同方法.
相关概念视频
Cancer Survival Analysis
336
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
336
Cancer-Critical Genes II: Tumor Suppressor Genes
7.4K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.4K
Cancer-Critical Genes I: Proto-oncogenes
8.8K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.8K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Cancers Originate from Somatic Mutations in a Single Cell
11.8K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.8K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K


